|
|||||
|
|
Glycogenic hepatopathy is an under‐recognised cause of hepatomegaly and elevated liver transaminases in type 1 diabetes mellitus |
|
| Authors: | N. R. Irani K. Venugopal N. Kontorinis M. Lee R. Sinniah T. R. Bates |
| Affiliation: | 1. Department of Gastroenterology and Hepatology, Royal Perth Hospital, Perth, Western Australia, Australia;2. Department of General Medicine, Swan District Hospital, Perth, Western Australia, Australia;3. Department of Pathology, Royal Perth Hospital, Perth, Western Australia, Australia;4. School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia |
| Abstract: | Glycogenic hepatopathy (GH) is an under‐recognised complication of type 1 diabetes mellitus (T1DM) not controlled to target resulting in hepatomegaly and elevated liver transaminases. We report the case of a 19‐year‐old man with T1DM not controlled to target who presented with abdominal pain, hepatomegaly and deranged liver transaminases. He was subsequently diagnosed with GH on liver biopsy, with the mainstay of treatment being reduction in caloric intake and insulin. |
| Keywords: | hepatomegaly transaminitis diabetes glycogen liver |